Ira Dunkel
Memorial Sloan Kettering Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ira Dunkel as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:40 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT03389802 · Phase I Study of APX005M in Pediatric Central Nervous System TumorsPediatric Brain Tumor Consortium · completed · Glioblastoma Multiforme, High-grade Astrocytoma Not Otherwise Specified (NOS), CNS Primary Tumor, Not Otherwise Specified (NOS) · study chair
- Ph1NCT01049841 · Perifosine With Temsirolimus for Recurrent Pediatric Solid TumorsMemorial Sloan Kettering Cancer Center · completed · Pediatric Solid Tumors · principal investigator
- Ph2NCT01012609 · External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade AstrocytomasMemorial Sloan Kettering Cancer Center · completed · Brain Cancer · principal investigator
- Ph1NCT00776867 · Study of Single Agent Perifosine for Recurrent Pediatric Solid TumorsMemorial Sloan Kettering Cancer Center · completed · Solid Tumors · principal investigator
- N/ANCT00582049 · Research on the Environment and Children's Health: RetinoblastomaMemorial Sloan Kettering Cancer Center · completed · Retinoblastoma · principal investigator
- Ph2NCT00002675 · Chemotherapy in Treating Patients With RetinoblastomaMemorial Sloan Kettering Cancer Center · completed · Retinoblastoma · study chair
- Ph2NCT00003754 · Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood CancersMemorial Sloan Kettering Cancer Center · completed · Unspecified Childhood Solid Tumor, Protocol Specific · study chair
- Ph2NCT00003173 · High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid TumorsMemorial Sloan Kettering Cancer Center · completed · Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor · study chair
- N/ANCT00058370 · Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With MedulloblastomaMemorial Sloan Kettering Cancer Center · completed · Brain and Central Nervous System Tumors · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:40 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Pediatric Brain Tumor Consortium A multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumorsUM1CA081457 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · fiscal years 2016 to 2026 · $1,423,203 awarded in 2026Grant number is on one of their registry trials
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer Center AdministrationP30CA008748 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ALEX MACDONALD · fiscal years 2011 to 2026Named on NCT00003173
Most cited trial papers
Clinical-trial papers with this author name in diffuse midline glioma (dipg), ranked by citations from NIH iCite, fetched 2026-11-12 10:40 UTC. The ranking covers the 200 most relevant of 11 PubMed records, and a shared surname and initials can bring in a namesake. All 11 on PubMed
- A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study.Neuro Oncol · 202082 citationsRCR 3.7
- Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908.Neuro Oncol · 202368 citationsRCR 5.2
- Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047).Neuro Oncol · 202367 citationsRCR 6.0
- A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors.Pediatr Blood Cancer · 201753 citationsRCR 1.7
- Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma.Neuro Oncol · 201446 citationsRCR 1.4
- A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors.PLoS One · 201742 citationsRCR 1.4
- Advanced ADC Histogram, Perfusion, and Permeability Metrics Show an Association with Survival and Pseudoprogression in Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium.AJNR Am J Neuroradiol · 202019 citationsRCR 1.2
- Phase 1 dose-escalation trial using convection-enhanced delivery of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma.Neuro Oncol · 202518 citationsRCR 5.0
- 10 citationsRCR 0.6
- 7 citationsRCR 0.3